Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

We recently published Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst. Novo Nordisk A/S (NYSE:NVO) ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Novo Nordisk has reduced the prices of Wegovy by 37%. The obesity pen's lowest dose of 0.25 mg will sell at Rs 10,850 for a monthly pack.

Health officials have repeatedly warned Britons against buying the jabs on social media and to be aware of scam online ...

While Ozempic has gained global popularity for treating type-2 diabetes and consequently triggering weight loss, many are now ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

Tim Seymour, Seymour Asset Management CIO, said in a recent program on CNBC that markets remain worried about AI valuations ...

Healthy people are injecting tiny doses of obesity medication to look and feel even better. But at what risk?

Eli Lilly has cut cash prices for its weight-loss drug Zepbound on LillyDirect, lowering monthly costs to $299–$449. The move ...

DoP mulls exemption of 84 more drugs from public procurement rules that restrict global tender: Gireesh Babu, New Delhi Tuesday, November 25, 2025, 08:00 Hrs [IST] The Department ...